REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights
PR Newswire•29/10/2026•07:05 ET
0
Key Highlights
- ➤REGENXBIO will report Q3 2026 financial results on November 5
- ➤Conference call begins November 5 at 8:00 a.m. ET
- ➤Company advances late-stage gene therapies for rare and retinal diseases
REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights PR Newswire
ROCKVILLE, Md., Oct. 29, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Thursday, November 5, at 8:00 a.m. ET to discuss its financial results for the third quarter ended September 30, 2026, and operational highlights.
Get started
Create a free account to read the full story.